REFERENCES
- Miller RR, Feingold A, Paxinos J. Propoxyphene hydrochloride—a critical review. JAMA. 1970;213:996–1006.
- Dextropropoxyphene. In: Sweetman S, ed. Martindale: The complete drug reference, 35th ed. Pharmaceutical Press (Publications division of the Royal Pharmaceutical Society of Great Britain), London: 2007.
- Young RJ. Dextropropoxyphene overdosage: Pharmacological considerations and clinical management. Drugs. 1983;26:70–79.
- Ramsay BC. Complete nerve deafness after abuse of co-proxamol. Lancet. 1991;338:446–447.
- Rosenberg WMC, Ryley NG, Trowell JM, McGee JO, Chapman RW. Dextropropoxyphene induced hepatotoxicity: a report of nine cases. J Hepatol. 1993;19:470–474.
- Young RJ, Lawson AAH. Distalgesic poisoning—cause for concern. BMJ. 1980;12:1045–1047.
- Madsen SP, Strom J, Reiz S, Sorensen BM. Acute propoxyphene self-poisoning in 222 consecutive patients. Acta Anaesthesiol Scand. 1984;28:661–665.
- Ng B, Alvear M. Dextropropoxyphene addiction—a drug of primary abuse. Am J Drug Alcohol Abuse. 1993;19:153–158.
- Saboory E, Derchansky M, Ismaili M, Mechanisms of morphine enhancement of spontaneous seizure activity. Anesth Analg. 2007;105:1729–1735.
- Gutstein HB, Akil H. Opioid analgesics. In: Brunton L, ed. Goodman and Gilman's the pharmacological basis of therapeutics. 11th ed. New York, NY: McGraw-Hill; 2005:547–590.
- Steinhauer HB, Hertting G. Lowering of the convulsive threshold by non-steroidal anti-inflammatory drugs. Eur J Pharmacol. 1981;69:199–203.
- Shrivastava MP, Makde SD, Paranjpe BD. Interaction of ciprofloxacin with diclofenac and paracetamol in relation to its epileptogenic effect. Indian J Physiol Pharmacol. 1997;41:164–166.
- Deng JF, Spyker DA, Rall TW, Steward O. Reduction in caffeine toxicity by acetaminophen. J Toxicol Clin Toxicol. 1982;19:1031–1043.
- Rathlev NK, Ulrich AS, Delanty N, D'Onofrio G. Alcohol-related seizures. J Emerg Med. 2006;31:157–163.
- Little HJ. The benzodiazepines: anxiolytic and withdrawal effects. Neuropeptides. 1991;19 Suppl:11–14.
- Barkin RL, Barkin SJ, Barkin DS. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity. Am J Ther. 2006;13:534–542.
- Willens JS. Consumer group urges Food and Drug Administration to ban Darvon (editorial). Pain Manag Nurs. 2006;7:43.